Wayfinder's Well
Free guides
Diabetes

Your Gut and Your Blood Sugar: The Microbiome Connection Most Type 2 Plans Skip

A naturopathic look at why the gut microbiome shapes insulin resistance, and why blood sugar plans that skip it tend to plateau.

Dr. Joyce Knieff, ND·May 12, 2026·7 min read
Bowl of oats, fresh berries, and yogurt on a white wood table, with a small jar of yogurt and a sprig of pink roses

Image by Pexels via Pixabay

Your Gut and Your Blood Sugar: The Microbiome Connection Most Type 2 Plans Skip#

If you have Type 2 diabetes or prediabetes and you've been doing the work (cutting carbs, losing some weight, moving more, taking the metformin) and your numbers still won't budge the way you expected, there's usually a piece of the picture the standard plan didn't address. It's not motivation. It's usually not effort. It's the gut microbiome, the trillions of bacteria living mostly in your colon, and what they do with what you eat. In the patients I see who fit this pattern, the gut is almost always where we find the part that got skipped.

The evidence on this has shifted a lot in the last decade. It used to be a fringe conversation. It is not anymore. For the wider diabetes picture, I keep that broader view here. This post is about why your gut and your blood sugar are part of the same conversation.

How your gut talks to your pancreas#

Your gut bacteria are not bystanders. They ferment your fiber, send chemical messages into the rest of your body, train your immune system, and patrol the wall between your intestine and your bloodstream. Each of those jobs is connected to how your body handles sugar.

When that ecosystem tips toward fewer species and a more inflammatory tone, what microbiologists call dysbiosis, a slow chain of things starts to happen. The gut wall loosens a little. Small pieces of bacterial debris pass into circulation. The liver and fat tissue read those pieces as an inflammatory signal, and the body's insulin response gets a little less crisp. None of this is dramatic the way an acute illness is. It is a low background hum that nudges the system over years, and by the time it shows up on a glucose panel it has usually been at work for a while.

A 2023 paper in Nature added a more specific layer to this picture. Combining human stool, metagenomic sequencing, and host metabolic data, the researchers found that people with insulin resistance had elevated fecal monosaccharides, simple sugars sitting in stool that should already have been used up, and a distinct microbial carbohydrate-metabolism signature. Their gut bacteria were extracting and processing sugars differently from the bacteria in metabolically healthy people. When the researchers then transferred the "insulin-sensitivity-associated" bacteria into mice, the mice's metabolic phenotypes improved. The relationship between gut microbes and insulin sensitivity is not just correlative anymore. Specific microbial behaviors appear to be doing work.

Short-chain fatty acids and insulin sensitivity#

The clearest molecular link is a small family of molecules called short-chain fatty acids, or SCFAs. The three you'll hear about most are acetate, propionate, and butyrate. Your gut bacteria make them when they ferment dietary fiber in your colon. They are not waste products. They are chemical messengers that travel into circulation and act on fat tissue, muscle, the liver, and even the pancreas.

A Nature Reviews Endocrinology review walked through this carefully. Across cell, animal, and a growing set of human studies, the three SCFAs work together to support glucose handling, through effects on appetite, energy use, and how muscle and liver clear sugar from the blood. The authors are cautious about the human-intervention data, which is fair. The mechanistic direction, though, has held up for a full decade now.

Here is the inconvenient part: you cannot shortcut this. SCFAs are not a supplement you can swallow in a way the data supports. They have to be made in your own colon, by your own bacteria, out of fiber you actually ate.

The fiber gap that breaks the loop#

This is where modern eating gets us. Adults in industrialized countries eat far less fiber than their grandparents did, and many of the fibers our grandparents got (diverse, fermentable, plant-cell-wall material) have been replaced by softer carbohydrates that the small intestine absorbs before the colon ever sees them.

Most of the people I see in clinic for blood-sugar trouble are eating almost no fermentable fiber, even when they think they are eating well. Low-carb, gluten-free, dairy-free plans can quietly become low-fiber plans, and the gut shows it. The shift toward fewer-but-cleaner foods is not always a gain for your microbes. It is a real pattern I keep meeting.

When the colon does not get fiber, the SCFA-producing bacteria shrink. The community shifts. The wall thins. The signaling that was helping keep your insulin response sharp grows quieter. A 2021 Nutrients review described the loop carefully. Western diets, low in fiber, are linked to both altered gut microbial signatures and the metabolic profile of insulin resistance, and dietary fiber appears to reverse parts of this pattern by feeding the right microbes again.

This is one of the reasons cutting carbs alone often takes people only so far. You can reduce the glucose load hitting your blood without ever feeding the part of your gut that helps you handle glucose in the first place. The two changes, less refined starch and more fermentable fiber, look adjacent on a food label. They are not the same intervention.

What the human trials show so far#

Most of what we know in humans is still observational. People with Type 2 diabetes tend to have certain microbial signatures, and people with healthier metabolic profiles tend to have others. The causal arrows are messy. But intervention trials are starting to land, and one is worth knowing about.

In 2019, a Belgian research group ran a small, careful trial. They gave overweight, insulin-resistant adults a daily dose of Akkermansia muciniphila, a single gut bacterium that lives in the protective mucus layer of the intestine and is consistently low in people with metabolic disease. Three months later, the pasteurized form of that one bacterium had improved insulin sensitivity by about 29% compared to placebo, dropped fasting insulin by roughly a third, and modestly improved cholesterol, without safety issues. Thirty-two people finished the trial, which is small, and the authors framed it as proof-of-concept, which is correct. But this is the kind of signal that, when you see it, you keep watching.

For the broader complication picture (kidney disease, retinopathy, cardiovascular risk in people with Type 2), microbiome differences also show up consistently across studies, and the severity of the dysbiosis tracks with the severity of the complications. That suggests these gut shifts are not just early markers but may keep shaping how the disease progresses over time.

Honestly, we are not yet at the point where a gastroenterologist can sequence your stool, hand you a tailored probiotic, and resolve your insulin resistance. We are at the point where the gut-metabolic connection is solid enough that leaving it out of a Type 2 plan leaves a real piece of the picture on the table.

Where this leaves you#

If you take one thing from this post, let it be the feeding loop. Fiber feeds the microbes, the microbes make SCFAs, and the SCFAs help tune insulin sensitivity. It is a slow loop. Not the kind of intervention that gives you a number to point to next week. The kind that compounds over months, sometimes years, mostly invisibly, until one day a routine A1C comes back two points lower than you were braced for.

Practically, that looks like building meals around fermentable plant fiber (beans and lentils, oats, ground flax, berries, leafy greens, the cabbage family) and giving your gut time to repopulate. Notice whether fermented foods like sauerkraut, kefir, kimchi, or yogurt with live cultures feel good in your gut, and include them when they do. And keep your gut in the conversation alongside your blood sugar, not in place of it.

I will be saying more about this in the diabetes course we are building inside Wayfinder's Well. The gut piece is one of several places I think the standard Type 2 conversation has a gap, and the course is where I am pulling those threads together.

If you want a more structured approach to metabolic health, Wayfinder's Well membership is where my full course library, including the upcoming diabetes course, lives.

References

  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.